Effects of a MAPK p38 inhibitor on lung function and airway inflammation in equine recurrent airway obstruction.

Lavoie, J P; Thompson, D; Hamilton, E; Debrue, M; David, F; Hickey, G

Lavoie, J P; Thompson, D; Hamilton, E; Debrue, M; David, F; Hickey, G.

Affiliation

Lavoie JP; Faculté de médecine vétérinaire, Université de Montréal, C.P 5000, Saint-Hyacinthe, Quebec J2S 7C6, Canada.

Equine Vet J ; 40(6): 577-83, 2008 Sep.

Article in En | MEDLINE | ID: mdl-19031513

Subject(s)

Bronchoalveolar Lavage Fluid/cytology; Horse Diseases/drug therapy; Horse Diseases/prevention & control; Lung Diseases, Obstructive/veterinary; p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors; Animals; Anti-Inflammatory Agents/therapeutic use; Dexamethasone/therapeutic use; Female; Horses; Inflammation/drug therapy; Inflammation/prevention & control; Inflammation/veterinary; Injections, Intravenous/veterinary; Lung/drug effects; Lung/pathology; Lung Diseases, Obstructive/drug therapy; Lung Diseases, Obstructive/prevention & control; Male; Recurrence; Respiratory Function Tests/veterinary; Severity of Illness Index; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bronchoalveolar Lavage Fluid / P38 Mitogen-Activated Protein Kinases / Horse Diseases / Lung Diseases, Obstructive Limits: Animals Language: En Journal: Equine Vet J Year: 2008 Document type: Article Affiliation country: Canada

Search on Google

Add to My VHL

XML

PubMed Links